A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants
Clinical trial NCT03142165 · COMPLETED
Trial details
- NCT number
- NCT03142165
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-11
- Primary completion
- 2017-11-29
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.